AzTrials
AzTrials

PovertyPhase 1SUUBINCT01163695

The SUUBI Program: Asset-Ownership for Orphaned Children in Uganda

A Phase 1 study testing Children's development account in people with Poverty, run by Columbia University at 1 site in Uganda.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examines an economic empowerment model of care and support for orphaned adolescents in rural Uganda. The Suubi intervention focuses on economic empowerment of families caring for orphaned youths. Read more about this study

Who is it for?
Ages 11 to 17 years
Conditions the study is for
Poverty
What is being tested?
Children's development account
How many people
286 participants
Where
1 siteUganda
Study dates
Jun 2005to Jan 2009
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • an orphaned child, defined as a child who has lost one or both parents to HIV/AIDS; enrolled in primary school (even though possibly not attending regularly); between the ages of 12 to 15 years.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Uganda1 site
  • St. Joseph's Matale Parish

    Rakai, Rakai

Other trials in Uganda

About this study

Official title: The SUUBI Program: Creating Asset-Ownership Opportunities and Health Promotion Among Orphaned Children in Uganda

This study examines an economic empowerment model of care and support for orphaned adolescents in rural Uganda. The Suubi intervention focuses on economic empowerment of families caring for orphaned youths. It attempts to address the health risks and poor educational achievements resulting from poverty and limited options.

Read the detailed description

The AIDS epidemic and a 20-year civil war have had a devastating impact on Uganda. The events have led to population displacement, worsening living conditions, exacerbation of poverty, and disruption of already weakened social service systems. As implemented, the Suubi Project goes considerably beyond the usual care, which primarily consists of institutionalization and reactive strategies (involving food and material aid). Specifically, the intervention promotes children's savings accounts, also known as children development accounts, for postprimary education and microenterprise development (i.e., development of small income-generating businesses).

The Suubi intervention is grounded in asset theory (Sherraden 1990, 1991), which holds that assets (e.g., savings, educational opportunities, and economic opportunities in the form of income-generating activities or microenterprises) have important economic, social, and psychological benefits for individuals and families. Asset building is increasingly viewed as a critical factor for reducing poverty, improving psychosocial functioning, and positively affecting attitudes and behaviors.

Conditions
Poverty
Being tested
Children's development account
Keywords
economic empowerment model, orphans, sub-Saharan Africa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Children's development accountBehavioural

    Also called Children's savings account

    Children in the experimental condition (the SUUBI program) received, in addition to the usual care, an economic empowerment intervention aimed at promoting asset accumulation for families-and consisting of three major components: 1) workshops focused on asset-building and future planning; 2) a monthly mentorship program for adolescents with peer mentors on life options; and 3) a Child Development Account (CDA), dedicated to paying for secondary schooling, vocational training and/or a family small business. The CDAs were matched savings accounts, with a match rate of 2:1 as an incentive for participants to save, but with a limit on the maximum savings that could be matched (the match cap, in this case, was equivalent to $10 a month).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Savings and asset-accumulation

    past experience, current savings, and attitudes toward saving

    Measured: baseline, 10-month and 20-month post-intervention

Secondary outcomes (4)
  1. Sexual risk taking

    Sexual risk taking behavior (history and onset of sexual intercourse), Intentions to engage in sexual risk behaviors

    Measured: baseline, 10-month and 20-month post-intervention

  2. Educational outcomes

    School enrollment, School attendance, School grades, Educational aspirations

    Measured: baseline, 10-month, and 20-month post-intervention

  3. Mental health

    Self-esteem, depression, hopelessness, helplessness

    Measured: baseline, 10-month and 20-month post-intervention

  4. Social and family support

    Emotional support from caregivers, practical assistance, financial assistance and advice/guidance, and family communication

    Measured: baseline, 10-month and 20-month post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2010 (estimated)
  2. Study startJun 2005
  3. Primary completionJun 2008
  4. Study completionJan 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
286 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01163695
Sponsor's protocol ID
AAAA5337
Other IDs
R21MH076475-01
Acronym
SUUBI
Status last verified
Mar 2014
First submitted
14 Jul 2010
Last updated
14 Mar 2014
Results posted
No
Data monitoring committee
No

Publications

  • Ssewamala FM, Ismayilova L, McKay M, Sperber E, Bannon W Jr, Alicea S. Gender and the effects of an economic empowerment program on attitudes toward sexual risk-taking among AIDS-orphaned adolescent youth in Uganda. J Adolesc Health. 2010 Apr;46(4):372-8. doi: 10.1016/j.jadohealth.2009.08.010.

    PubMed 20307827
  • Ssewamala FM, Han CK, Neilands TB, Ismayilova L, Sperber E. Effect of economic assets on sexual risk-taking intentions among orphaned adolescents in Uganda. Am J Public Health. 2010 Mar;100(3):483-8. doi: 10.2105/AJPH.2008.158840. Epub 2010 Jan 14.

    PubMed 20075323
  • Ssewamala FM, Han CK, Neilands TB. Asset ownership and health and mental health functioning among AIDS-orphaned adolescents: findings from a randomized clinical trial in rural Uganda. Soc Sci Med. 2009 Jul;69(2):191-8. doi: 10.1016/j.socscimed.2009.05.019. Epub 2009 Jun 10.

    PubMed 19520472
  • Ssewamala FM, Alicea S, Bannon WM Jr, Ismayilova L. A novel economic intervention to reduce HIV risks among school-going AIDS orphans in rural Uganda. J Adolesc Health. 2008 Jan;42(1):102-4. doi: 10.1016/j.jadohealth.2007.08.011.

    PubMed 18155037
  • Ismayilova L, Ssewamala FM, Karimli L. Family support as a mediator of change in sexual risk-taking attitudes among orphaned adolescents in rural Uganda. J Adolesc Health. 2012 Mar;50(3):228-35. doi: 10.1016/j.jadohealth.2011.06.008. Epub 2011 Aug 27.

    PubMed 22325127

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Children's development account in people with Poverty, run by Columbia University at 1 site in Uganda.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Savings and asset-accumulation (time frame: baseline, 10-month and 20-month post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01163695, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in